Eris Lifesciences Limited (BOM:540596)
1,319.50
-8.40 (-0.63%)
At close: Nov 20, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 182.75 billion as of November 20, 2026. Its market cap has decreased by 16.72% in one year.
Market Cap
182.75B
Enterprise Value
204.47B
Revenue
33.12B
Global Rank
n/a
Country Rank
n/a
PE Ratio
25.73
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 182.75B, an increase of 120.96%. That is a compound annual growth rate of 8.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 182.75B | -10.89% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 353.36B |
| Piramal Pharma | 317.20B |
| Alembic Pharmaceuticals | 205.40B |
| Eris Lifesciences | 182.30B |
| Cohance Lifesciences | 176.95B |
| Alivus Life Sciences | 176.79B |
| NATCO Pharma | 159.88B |
| Sudeep Pharma | 134.74B |